Effect of phenylephrine vs. ephedrine on frontal lobe oxygenation during caesarean section with spinal anesthesia: an open label randomized controlled trial by Visti T. Foss et al.
ORIGINAL RESEARCH ARTICLE
published: 03 March 2014
doi: 10.3389/fphys.2014.00081
Effect of phenylephrine vs. ephedrine on frontal lobe
oxygenation during caesarean section with spinal
anesthesia: an open label randomized controlled trial
Visti T. Foss1*, Robin Christensen2, Kim Z. Rokamp1, Peter Nissen3, Niels H. Secher3 and
Henning B. Nielsen3
1 Department of Anaesthesia, Næstved Hospital, Næstved, Denmark
2 Musculoskeletal Statistics Unit, Department of Rheumatology, The Parker Institute, Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark
3 Department of Anaesthesia, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Edited by:
Patrice Brassard, Laval University,
Canada
Reviewed by:
Ashraf Habib, Duke University, USA
Samuel J. E. Lucas, University of
Birmingham, UK
*Correspondence:
Visti T. Foss, Department of
Anaesthesia, Næstved Hospital,
Ringstedgade 61, 4700 Næstved,
Denmark
e-mail: vistifoss@gmail.com
Background: During caesarean section spinal anesthesia may provoke maternal
hypotension that we prevent by administration of phenylephrine and/or ephedrine.
Phenylephrine is however reported to reduce the near infrared spectroscopy-determined
frontal lobe oxygenation (ScO2) but whether that is the case for patients exposed to spinal
anesthesia is not known.
Objectives: To evaluate the impact of phenylephrine vs. ephedrine on ScO2during
caesarean section with spinal anesthesia in a single center, open-label parallel-group study
with balanced randomization of 24 women (1:1). Secondary aims were to compare the
effect of the two drugs on maternal hemodynamics and fetal heart rate.
Intervention: Ephedrine (0.8–3.3mg/min) vs. phenylephrine infusion (0.02–0.07mg/min).
Results: For the duration of surgery, administration of ephedrine maintained ScO2
(compared to baseline +2.1 ± 2.8%; mean ± SE, while phenylephrine reduced ScO2
(−8.6 ± 2.8%; p = 0.005) with a 10.7% difference in ScO2between groups (p = 0.0106).
Also maternal heart rate was maintained with ephedrine (+3 ± 3 bpm) but decreased with
phenylephrine (−11 ± 3 bpm); difference 14 bpm (p = 0.0053), but no significant difference
in mean arterial pressure (p = 0.1904) or CO (p = 0.0683) was observed between groups.
The two drugs also elicited an equal increase in fetal heart rate (by 19 ± 3 vs. 18 ± 3 bpm;
p = 0.744).
Conclusion: In the choice between phenylephrine and ephedrine for maintenance of blood
pressure during caesarean section with spinal anesthesia, ephedrine maintains frontal
lobe oxygenation and maternal heart rate with a similar increase in fetal heart rate as
elicited by phenylephrine.
Trial registration: Clinical trials NCT 01509521 and EudraCT 2001 006103 35.
Keywords: cerebral autoregulation, drug effect, heart rate, fetal, near infrared spectroscopy, vasoconstrictor agents
INTRODUCTION
Spinal anesthesia is used for caesarean section although it is com-
monly associated with hypotension. In addition to tilting patient
to the left and providing i.v. fluids, we use ephedrine and/or
phenylephrine to prevent or correct hypotension that could result
in, e.g., dizziness, nausea, and vomiting and also hinder adequate
perfusion of the child (Berlac and Rasmussen, 2005; Cyna et al.,
2006; Saravanan et al., 2006; Ngan Kee et al., 2008a).
The effect of ephedrine and phenylephrine on maternal and
fetal hemodynamics has been investigated extensively (Mercier
et al., 2001; Saravanan et al., 2006; Langesaeter et al., 2008; Ngan
Kee et al., 2008a) There seems to be no difference between the
two drugs in regards to preventing hypotension following spinal
anesthesia for caesarean section (Cyna et al., 2006) However,
fetal tachycardia appears to be more frequent with the use of
ephedrine, or combined ephedrine and phenylephrine than with
the use of phenylephrine (Wang et al., 2011) Furthermore, the
effect of phenylephrine on fetal acid base status seems to be more
favorable than manifested with the use of ephedrine (Vesser et al.,
2012).
On the other hand, near infrared spectroscopy (NIRS) deter-
mined cerebral (frontal lobe) oxygenation (ScO2) decreases when
hypotension is supported by phenylephrine (Nissen et al., 2009a,
2010; Ogoh et al., 2011; Meng et al., 2011a) while it is main-
tained with the use of ephedrine (Nissen et al., 2010; Meng
et al., 2011a; Ogoh et al., 2011) We investigated how phenyle-
phrine and ephedrine influence ScO2 when used to prevent
maternal hypotension during caesarean section performed under
spinal anesthesia where phenylephrine may hinder accumulation
of blood in the blocked area of the body and thereby support
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cardiac output (CO)(Cannesson et al., 2012) and in turn ScO2.
Thus, we hypothesized that administration of both ephedrine
and phenylephrine would maintain ScO2 in patients undergoing
caesarean section with spinal anesthesia since an increase in vas-
cular tone can enhance venous return and thereby support cardiac
preload and CO during hypovolemia as demonstrated in anes-
thetized pigs (Cannesson et al., 2012) In this randomized clinical
trial the primary outcome was to evaluate the ScO2 response
to administration of ephedrine vs. phenylephrine. Secondary
aims were to evaluate changes in maternal hemodynamics and
in fetal heart rate. Umbilical cord blood gas variables were also
determined.
METHODS
For this single center, open label, parallel-group study with
balanced randomization (1:1), written informed consent was
obtained from healthy women undergoing elective caesarean
section during spinal anesthesia after approval by the local
ethics committee (SJ—271) and the Danish medicine agency
(NCT 01509521; EudraCT 2001 006103 35). The Good Clinical
Practice (GCP) unit at the University of Copenhagen mon-
itored the trial conducted from April 2012 to July 2012 at
Næstved Hospital. Eligible participants were older than 18
years in ASA group I or II, 160–180 cm and with a sin-
gle pregnancy. Patients with either preeclampsia, non-singleton
pregnancy, HELLP-syndrome (hemolysis, elevated liver enzyme,
low platelet count), elevated serum bilirubin, or reported
allergy to ephedrine or phenylephrine were excluded from the
study.
PREPARATION
Upon arrival to the operating theater, the patient was provided
with 500mL isotonic saline, tilted 15◦ to the left and nasal sup-
plementation of oxygen (2 L/min) was established. A cuff was
applied to the third finger of the left hand and heart rate (HR),
systolic (SBP), diastolic (DBP) and mean arterial (MAP) blood
pressures were determined by Nexfin (BMEYE, The Netherlands,
Amsterdam). Thus stroke volume (SV) was determined from the
pressure curve using Modelflow (Bogert and van Lieshout, 2005)
that takes sex, age, and weight into account. CO (SV times HR)
and total peripheral resistance (TPR; MAP divided by CO) were
calculated. Nexfin data were obtained on a beat to beat basis
and averaged over 15 s every 2.5min. Fetal HR was obtained by
Doppler (Sonicaid Dopplers, Luton, Huntleigh, UK) and aver-
aged over 15 s from before spinal anesthesia (baseline) and after
spinal anesthesia (2.5–5min), during surgery (7.5–17.5min), and
after delivery (13–28min).
SPINAL ANESTHESIA
With 2.4mL bupivacaine 0.5% (12mg) and 10μg fentanyl spinal
anesthesia was established using a 27 or 25G pencil point nee-
dle at the L2–L3 or L3–L4 intervertebral space. Spinal anesthesia
was administered in the right lateral position in 21 patients and
in three patients spinal anesthesia was provided in a seated posi-
tion. Surgery started when the sensory block included the T5
dermatome as indicated by the loss of sensation to application
of cold to the skin.
FRONTAL LOBE OXYGENATION
ScO2 was monitored by NIRS (INVOS 3100 Cerebral Oxymeter,
Somanetics, Troy, USA). Optodes were placed on both sides of
the forehead immediately below the hairline and secured with
a headband that also served to seal ambient light. The NIRS-
determined mean ScO2 is based on optodes that emit and detect
near-infrared light at two wavelengths (730 and 810 nm) and
ScO2 is calculated as the ratio between oxyhemoglobin and total
hemoglobin. The signal detector closest to the light source (3 cm)
is considered the “shallow detector” and used to attenuate influ-
ence from superficial tissue, while the detector 4 cm from the light
source is considered to detect light from “deep tissue.” The dis-
tance between the source and detectors is considered sufficient for
light to reach the brain (Choi et al., 2004) Thus it was assumed
that values are accounted for predominantly by hemoglobin in
the frontal lobe cortex, although a contribution from the skin is
acknowledged (Davie and Grocott, 2012).
INTERVENTIONS AND RANDOMIZATION
The patients were allocated randomly into two groups (ephedrine
or phenylephrine) of 12 using sequentially numbered, opaque,
sealed envelopes prepared by an individual not involved in the
study. Dose equivalence between phenylephrine (0.1mg/mL) and
ephedrine (5mg/mL) was chosen in according to previous trials
and recommendations (Saravanan et al., 2006; Ngan Kee et al.,
2008b; Das et al., 2011).
After spinal anesthesia, the infusion was started (20ml/h;
1.6mg/min for ephedrine and 0.03mg/min for phenylephrine)
and adjusted to maintain SBP. If SBP increased from baseline
by 10–20%, the infusion was reduced to 10mL/h and paused
if SBP increased more than 20%. Conversely, if SBP decreased
by 10–20%, the infusion was increased to 40mL/h. A bolus
of either 10mg ephedrine or 0.2mg phenylephrine was to be
administered if SBP decreased by more than 20%, or if the
patient complained of symptoms of hypotension (dizziness, vom-
iting, faintness, nausea). At delivery the infusion was reduced
to 10mL/h and terminated 5–15min thereafter. Data collected
included Apgar score, and umbilical arterial and venous blood gas
variables from a double-clamped cord segment. Further, data per-
taining to the duration of surgery, volume of saline administered
and the vasopressor dosages used are mentioned.
OUTCOME MEASURES
The primary outcome is expressed as the percentage ScO2 change
from baseline, with baseline defined as rest prior to spinal anes-
thesia (time 0min). The secondary outcomes variables (maternal
hemodynamics and fetal heart rate) were also expressed as the
change from baseline and all observations were continued until
the end of surgery.
STATISTICAL ANALYSIS
Power calculations based on former studies (Nissen et al., 2010;
Kim et al., 2000) revealed that in order to detect a statisti-
cally significant difference between means of 57 and 67% in
ScO2, assuming a common standard deviation of 7%, a sam-
ple size of n = 9 per group was required to obtain a power of
a least 0.8 (β = 20%; two-tailed α = 5%). To compensate for
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potential dropouts and missing data (25%) the sample size was
increased to 12 participants per group. Data analyses were accord-
ing to a pre-established plan using SAS software (v. 9.2; SAS
Institute Inc., Cary, NC, USA). Descriptive statistics and tests
are reported in accordance with the “Enhancing the QUAlity
and Transparency Of health Research” (EQUATOR) network: the
CONSORT Statement (Schulz et al., 2010). In order to evaluate
data distribution of the outcome and statistical models, inspec-
tion was used to suggest whether the assumption of normality
was reasonable. The PROC UNIVARIATE statement was used
to summarize descriptive data. If the assumption of normality
was not reasonable, we analyzed the data with the nonparamet-
ric Wilcoxon Rank Sum test using PROC NPAR1WAY; and the
median difference was reported. The 95% confidence limit was
estimated from an approximated standard error, based on the
Wilcoxon p-value from a Wald-Z-test.
To analyse the longitudinal element of the study objectives, a
linear approach was used for repeated measurements, using the
procedure PROC MIXED based on restricted maximum likeli-
hood (REML) estimates of the variables (Littell et al., 2000). The
factor Subject was applied as a random effect factor. Assessment
of the treatment and time effects tested possible interaction and
both treatment and time were included as systematic factors using
the baseline value as co-variate to reduce random variation and
increase power. Unless stated otherwise, results are expressed as
the difference between the group means and 95% CI with the
associated p-values, based on the mixed linear model. The aver-
age change from the baseline during the study in each group was
analyzed based on the mixed model with only the main effects of
group and time without taking interaction into account. All com-
parisons were two tailed and p < 0.05 was considered statistically
significant.
RESULTS
PATIENTS
Written informed consent to participate in the study was obtained
from 33 patients; 24 of whom were subsequently randomized
(Figure 1) and the randomized patients had a body mass index
of 30.1 (5.4) mean (SD), range 21.6–41.6 kg/m2 (Table 1).
FRONTAL LOBE OXYGENATION
In patients allocated to administration of phenylephrine ScO2
decreased by −8.6 ± 2.8% while in patients randomized to
infusion of ephedrine, ScO2 was not affected (+2.1 ± 2.8%).
Comparing the values determined in the two groups, the dif-
ference in ScO2 was 10.7% (95% CI 2.8–18.7%, p = 0.0106:
Table 2, Figure 2). Whereas ScO2 was reduced from baseline in
the phenylephrine group (p = 0.005), this was not the case with
the administration of ephedrine (p = 0.4657).
CARDIOVASCULAR EFFECTS
Phenylephrine (−14 ± 3mmHg) and ephedrine (−20 ±
3mmHg) were equally effective in maintaining MAP (Figure 3)
with a group mean difference of 6mmHg (95% CI −15 to 3,
p = 0.1904). Similar results were obtained for DBP and SBP
(Table 2). The maternal HR was maintained with ephedrine
(+3± 3 bpm) but decreased with phenylephrine (−11± 3 bpm);
difference 14 (95% CI 5–23, p = 0.0053) bpm. SV appeared
to increase both with phenylephrine (9.7 ± 4.8ml) and with
ephedrine (4.4 ± 5.0ml), but this difference was not signif-
icant: −5.3ml (95% CI −18.9 to 8.3, p = 0.4299). In the
ephedrine group CO increased by 0.9 ± 0.4 l/min, while in
the phenylephrine group CO was stable (−0.1 ± 0.4 l/min);
95% CI −0.08 to 2.02, p = 0.0683). There was a tendency for
TPR to be lower in the ephedrine group compared with the
phenylephrine group (−232 ± 42 vs. −129 ± 41) dyn s cm−5
(p = 0.0684).
FETAL VARIABLES
The difference in fetal heart rate between the ephedrine and
phenylephrine group was 1 bpm (95% CI −6 to 9, p = 0.7441);
for ephedrine +19 ± 3 vs. +18 ± 3 bpm for phenylephrine
(Table 2, Figure 4). When compared to baseline both ephedrine
(p < 0.005) and phenylephrine (p < 0.005) increased fetal heart
rate. All Apgar scores were = 8 one minute after delivery and
increased to 10 after 5min in both groups. There was a difference
(p = 0.0223) in regard to the umbilical venous base excess: −1.0
(95% CI −0.86 to −0.14)mM and arterial umbilical lactate was
higher in the ephedrine than in the phenylephrine group: 0.50
(95% CI 0.09–0.91)mM, p = 0.017, while no differences were
observed in any of the other umbilical cord blood variables
assessed (Table 3).
OPERATIVE RESULTS
The time between intra-thecal injection and start of surgery [dif-
ference 0.0 (95% CI −2.8 to 2.8)min, p = 0.9976)] and between
intra-thecal injection and delivery [difference 0.2 (95% CI 0.2 to
3.2)min, p = 0.9106)] were similar for the ephedrine and the
phenylephrine groups (Table 4). The amount of i.v. saline was
also equal between the two groups: 63ml (95% CI −259 to 134,
p = 0.0515) and there was no difference in the blood loss (100ml
(95% CI of difference −275 to 475), p = 0.601).
VASOPRESSOR DOSE
The ephedrine dose per minute was 1.7mg (1.3–2) range 0.7–
5.9mg and of phenylephrine 1.38mg (0.91–1.55) range 0.57–
1.82mg. No patient was treated with both phenylephrine and
ephedrine.
Further monitoring (not reported) included pulse oximetry,
ECG, non-invasive blood pressure on the right arm after initia-
tion of saline administration and continued until the patient was
transferred to the postoperative observation unit (no abnormal
values were noted).
DISCUSSION
The present study confirmed that phenylephrine and ephedrine
are equally effective in maintaining MAP in patients undergoing
caesarean section with spinal anesthesia. The new finding is that
in patients undergoing spinal anesthesia, the use of the ephedrine,
capable of activating both α and β adrenergic receptors, preserves
the near infrared-determined frontal lobe oxygenation (ScO2)
while ScO2 was reduced in patients allocated to administration
of phenylephrine, a selective α-adrenergic receptor agonist. We
considered that women going through caesarean section during
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FIGURE 1 | Trial profile.
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Table 1 | Patient characteristics, cardiovascular values, fetal heart rate, and frontal lobe oxygenation at baseline.
Ephedrine Phenylephrine Total
N = 12 N = 12 N = 24
Age (years) 30.8±5.5 33.0±3.7 31.9±4.7 (21–39)
Height (cm) 166±6 168±7 167±6 (160–180)
Weight (kg) 89±20 81±8 85±15.5 (67–125)
Body mass index (kg/m2) 32.2±6.3 28.1±3.2 30.1±5.4 (21.6–41.6)
Systolic pressure (mmHg) 135±20 137±14 136±17 (104–168)
Diastolic pressure (mmHg) 83±9 80±13 81±11 (62–105)
Mean arterial pressure (mmHg) 102±11 101±12 101±11 (82–122)
Heart rate (bpm) 95±18 89±21 92±19 (59–132)
Stroke volume (ml) 97±21 105±20 101±20 (59–149)
Cardiac output (L/min) 8.9±1.1 9.0±2.1 8.9±1.6 (5.7–13.2)
Total peripheral resistance (dyn s cm−5) 933±162 946±262 940±213 (570–1530)
Fetal heart rate (bpm) 138±9 137±9 138±9 (120–150)
Frontal lobe oxygenation (%) 67±10 64±7 66±8 (56–91)
Values are means ± SD. (range: minimum and maximum).
Table 2 | Change in outcomes from baseline on average during 60min trial period, in patients randomized to either ephedrine or phenylephrine.
(n = 12) Ephedrine (n = 12) Phenylephrine Difference (95% CI) p-Value
Frontal lobe oxygenation (%) 2.1±2.8 −8.6±2.8 10.7 (2.8–18.7) 0.0106
Systolic pressure (mmHg) −19±5 −16±5 −3 (−17 to 11) 0.6329
Diastolic pressure (mmHg) −17±3 −14±2 −3 (−10 to 3) 0.3093
MAP (mmHg) −20±3 −14±3 −6 (−15 to 3) 0.1904
Heart rate (bpm) 3±3 −11±3 14 (5–23) 0.0053
Stroke volume (ml) 4.4±5.0 9.7±4.8 −5.3 (−18.9 to 8.3) 0.4299
Cardiac output (L/min) 0.85±0.39 −0.12±0.38 0.97 (−0.08 to 2.02) 0.0683
TPR (dyn s cm−5) −232±42 −129±41 −103 (214 to 8) 0.0684
Fetal heart rate (bpm) 19±3 18±3 1 (−6 to 9) 0.7441
Presented are the ephedrine and phenylephrine group with values in means ± SE (standard error) and differences in mean changes (95% CI). Values for frontal lobe
oxygenation (ScO2) are changes in percent.
spinal anesthesia might be hypovolemic because of compromised
venous return and that phenylephrine therefore could support
cardiac output and in turn cerebral oxygenation as expressed by
ScO2. In contrast to our hypothesis, however, phenylephrine did
not increase CO and maybe therefore reduced ScO2. In other
word, with the established routine for maintaining the circulation
during caesarean section during spinal anesthesia, CO in response
to administration of phenylephrine indicated that the patients
were maintained “normovolemic.” Furthermore, only ephedrine
maintainedHR and the two drugs elicited an equal almost 20 bpm
increase in fetal heart rate.
Spinal anesthesia influences MAP because of sympathetic
blockade and during caesarean section inferior caval compres-
sion may reduce venous return to the heart and thus CO (Cyna
et al., 2006) During caesarean section hypotension is considered
when maternal SBP decreases by 20–30% or decreases to less than
90–100mmHg (Saravanan et al., 2006; Ngan Kee et al., 2008a)
although we acknowledge that the lower limit of cerebral autoreg-
ulation has been challenged (Lucas et al., 2010; Tan, 2012). Thus,
MAP did not fall to what is considered to be the lower limit of
cerebral autoregulation (Paulson et al., 1990) and the patients
were not expected to be exposed to cerebral hypoperfusion and
a reduction in ScO2. However, administration of phenylephrine
led to a ∼9% reduction in ScO2 (Figure 2, Table 2). A decrease
in MAP to below ∼80mmHg, as provoked for example during
head-up tilt, reduces cerebral blood flow and ScO2 because of
a reduced central blood volume and CO (Madsen et al., 1998)
However, whether or not a balance exists between cerebral oxy-
gen supply and demand during anesthesia-induced hypotension
remains unknown (Meng et al., 2013).
A 10–15% reduction in ScO2 and a 50% reduction in mid-
dle cerebral artery mean flow velocity are associated with pre-
syncopal symptoms (Kurihara et al., 2007) The 9% reduction
in ScO2 in response to administration of phenylephrine dur-
ing spinal anesthesia for elective caesarean section approaches
that level and could thus represent clinically important cerebral
hypoperfusion (Hunt et al., 2006; Suzuki et al., 2008; Nissen
et al., 2009b). On the other hand, the patients were awake and
able to report hypotension-associated symptoms (nausea, vom-
iting or dizziness), but no complaints were expressed regardless
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FIGURE 2 | Change in ScO2 from baseline. Changes in frontal lobe
oxygenation (ScO2; % from baseline) during caesarean section with spinal
anesthesia. Patients received either phenylephrine (n = 12; open circles) or
ephedrine (n = 12; black circles).
FIGURE 3 | Change in mean arterial pressure from baseline. Changes in
mean arterial blood pressure (MAP) from baseline (mmHg) during
caesarean section with spinal anesthesia. Patients received either
phenylephrine (n = 12; open circles) or ephedrine (n = 12; black circles).
of the NIRS value. It is possible that the 9% reduction in ScO2
following the administration of phenylephrine reflects contam-
ination of the NIRS signal from extracranial tissue (Davie and
Grocott, 2012).
There was no difference in fetal HR among groups of patients
and neonatal outcome was similar, although there were small but
probably clinically unimportant differences in regard to umbilical
arterial lactate and venous base excess. Ephedrine could increase
fetal HR due to β-adrenergic stimulation, when or if it crosses pla-
centa inducing fetal acidaemia (LaPorta et al., 1995) The impact
FIGURE 4 | Foetal heart rate. Change in fetal heart rate (bpm) after
induction (2.5–5min), before surgery (7.5–17.5min), after delivery
(12.5–27.5min) in two groups of 12 patients undergoing spinal anesthesia
for caesarean section and receiving either phenylephrine (open circles) or
ephedrine (black circles).
of ephedrine on arterial lactate and venous base excess could be
related to an effect on uteroplacental or feto-placental circulation
(McGrath et al., 1994; LaPorta et al., 1995).
We recognize that this evaluation is not a blinded random-
ized controlled trial and further that it is a limitation to the study
that both physicians and nurses expected that ephedrine would
increase maternal heart rate and therefore potentially influenced
by that expectation.We estimated blood pressure 2.5min after ini-
tiation of anesthesia and with the use of vasopressor this consid-
ered as a long time and could represent a limitation of the study.
There were some difficulties in using Nexfin to estimate car-
diovascular variables during caesarean section when the patients
moved due to anxiety. Also, Modelflow may not be provide an
accurate CO (Remmen et al., 2002) and calibration by thermod-
ilution (Jansen et al., 2001) or by the Fick method (van Lieshout
et al., 2001) may be in need. However, for tracking changes in
CO the Nexfin has been successfully validated against a thermod-
ilution estimate during a deliberate reduction in central blood
volume induced by standing up in healthy subjects (Harms et al.,
1999) during cardiac surgery (Jansen et al., 2001) in intensive care
medicine (Jellema et al., 1999) and during liver transplantation
(Nissen et al., 2009c).
Phenylephrine preserved MAP and reduced HR and main-
tained CO with a slight increase in SV that was 5ml higher than
the increase in the subjects receiving ephedrine. Phenylephrine
may increase cardiac afterload to an extent that SV and CO
decrease. On the other hand, an increase in vascular tone can
increase venous return and thereby cardiac preload, SV and
CO during hypovolemia as demonstrated in anesthetized pigs
(Cannesson et al., 2012) Meng et al. found an increase in SV
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Table 3 | Umbilical cord blood analysis.
Variable Ephedrine Phenylephrine Difference between p-Value
groups (95% CI)
UMBILICAL ARTERIAL
pH 7.29 ± 0.08 7.31 ± 0.05 −0.02 (−0.07 to 0.04) 0.4699
Pco2; kPa 7.36 ± 1.63 6.98 ± 0.77 0.38 (−0.72 to 1.48) 0.4793
Base excess (mM)** −0.3 ± 2.8 0.6 ± 1.6 0.9 (−3.0 to 1.1) 0.3414
Lactate (mM) 2.4 [2.2 to 3.4] 1.9 [1.5–2.2] 0.50 (0,09–0.91)* 0.0170
UMBILICAL VENOUS
pH 7.37 ± 0.06 7.37 ± 0.04 0.00 (−0.04 to 0.04) 0.9350
Pco2; kPa 5.58 ± 1.00 5.95 ± 0.60 −0.37 (−1.10 to 0.37) 0.3083
Base excess (mM) −1.0 [−2.6 to −0.5] 0.0 [−0.1 to 0.3] −1.0 (−0.86 to −0.14)* 0.0223
Lactate (mM) 2.1 [1.4–2.6] 1.9 [1.5–2.2] 0.20 (−0,09 to 0.49)* 0.1738
Values are mean ± SD and differences in mean changes (95% CI). Exceptions are arterial and venous blood lactate, venous base excess which is shown as median
with interquartile range (IQR) in square brackets.
*Median difference.
Table 4 | Surgical times and intravenous fluid.
Variable Ephedrine Phenylephrine Difference between p-value
groups (95% CI)
Induction to incision (min) 13.3 ± 3.3 13.3 ± 3.3 0.0 (−2.8 to 2.8) 0.9976
Induction to delivery (min) 17.5 ± 3.2 17.3 ± 3.9 0.2 (−2.8 to 3.2) 0.9106
Total intravenous fluid (ml) 904 ± 254 967 ± 206 −63 (−259 to 134) 0.5153
Values are mean ± SD and differences in mean changes (95% CI).
and CO after administration of phenylephrine using pulsewave
analysis by Vigileo-FloTrac in non-pregnant patients, but the
increases were not confirmed with the use of a trans-esophageal
Doppler apparatus (Meng et al., 2011b). Also an increase in SV
in response to administration of phenylephrine is supported by
Doherty et al. who used a CO monitor based on bi-reactance
technology (Doherty et al., 2012) and by Dyer et al. using a
LiDCOplus monitor (Dyer et al., 2009).
Another limitation of this trial was that we measured ScO2
and not cerebral blood flow, but parallel variation between mid-
dle cerebral artery mean flow velocity in basal cerebral arteries
and ScO2 is reported (Ide et al., 1999; Yoshitani et al., 2007;
Steiner et al., 2009) Furthermore, determination of internal jugu-
lar venous oxygen saturation could validate if the data obtained
by NIRS are representative for the whole brain (Kim et al., 2000).
Three different NIRS approaches can be implemented: (1)
Continuous wave (CW), (2) Frequency-domain (FD), and (3)
time domain technology (TD). An approximate 3–4% decrease
in ScO2 is reported after treatment with phenylephrine with the
use of FD (Meng et al., 2011a), compared with the 9% decrease in
this evaluation while others (Nissen et al., 2010; Ogoh et al., 2011)
find an approximate decrease by 14% using CW. With commer-
cial CW monitors there is a variation in the ability to estimate
ScO2 (Davie and Grocott, 2012).
CONCLUSION
This study confirmed that infusion of phenylephrine and
ephedrine are equally effective for sustaining blood pressure
during elective caesarean section with spinal anesthesia.
Phenylephrine, however, reduced ScO2 and maternal heart rate
when compared to ephedrine but the two drugs induced an equal
increase in fetal heart rate.
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